Post-COVID Surge Manufacturing Progress
Source: Cytiva
In this segment of the Bioprocess Online Live event, Surge Manufacturing for Biopharma Resilience, University of Sheffield’s Dr. Zoltán Kis and TFF Pharmaceuticals’ Kayla Hannon discuss the rapid adoption of surge manufacturing principles like single use and modular design process trains in post-COVID biopharma scale-up and scale-out.
View the full presentation here.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more